It is the start of a New Year. People are saying 2016 has been pretty horrible, but 2016 has been pretty decent in regards to psychedelic science and research. We are hoping that 2017 will be a fruitful year as well.
In this episode Kyle and Joe run through the year in review — thoughts about the podcast and project as well as recap just a few of the psychedelic highlights of 2016. Continue reading “Psychedelics Today – Kyle and Joe – Year End Recap”
In this discussion, Natalie shares her insights surrounding U.S. and international policy around drugs. We talk about Continue reading “Natalie Ginsberg – Psychedelic Policy and Advocacy”
It has been a big week for psychedelic research. Psilocybin and MDMA have made national headlines. The New York Times article, “F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients,” highlights the recent win for MAPS in regards to their MDMA-assisted psychotherapy research. The FDA has given MAPS the green light to pursue phase 3 research for MDMA-assisted psychotherapy for post-traumatic stress disorder. Continue reading “Gabby Agin-Liebes – Can Psilocybin Help Ease Anxiety & Depression for Those Who Are Facing Death?”
Download
Joe and Kyle talk to Shannon Clare Petitt about the current state of MDMA research and what MAPS needs to do in the next number of months with the FDA as the phase three trials become approved. A few days after the interview the New York Times reported that the phase three research was approved. Shannon’s story is great and optimistic. If you are interested in how to get a job in the psychedelic field, this is certainly an episode you’ll want to listen to. We also discuss some possible tweaks to the studies that could be done that may yield interesting results, and also why MAPS is taking the approach that they are (its the most straightforward way to push the research through the FDA). Continue reading “Shannon Clare Petitt – MAPS, Zendo and an update on MDMA’s status”
Download
Kyle recently had the great opportunity to attend one module of the MAPS MDMA Therapy sessions. In this episode we talk about the experience at the workshop and about some other valuable topics as well. Let us know what you think, and please leave a review on iTunes! Continue reading “Kyle and Joe – MAPS MDMA training in New York”
In this episode Kyle and Joe speak about the recent interview they recorded with Dimitri Muganis. There were some relatively important points in the interview that needed further discussion and expansion and in this podcast we unravel some of the material. There is plenty more to unpack there.
Some of what is discussed in this episode includes.
Overall there are loads of things that we discussed, and in short the real message here is that we all need to keep moving forward. There is plenty of room for growth in the field for all of us to move our agendas forward.
With endless amounts of research left to be run, we can still treat people. I’m not sure we are going to see Psychedelic medicines be used in the next 1-2 years in major hospitals outside of research, but we are going to see it in the next decade for sure.
Lets keep moving and taking care of each other.
-Joe
Sign up for our mailing list here.
Neal M. Goldsmith, Ph.D. is a psychotherapist specializing in psychospiritual development. He is a popular speaker on drug policy reform, spiritual maturation, and the emergence of an integral society (a six-minute clip of his talk on the “Fusion of Spirit and Science” may be found at: http://vimeo.com/7517009) and an author, most recently of Psychedelic Healing: The Promise of Entheogens for Psychotherapy and Spiritual Development.
Dr. Goldsmith has curated dozens of successful conferences and cross-disciplinary “meetings of minds” for corporations as well as the psychedelic community, including the Horizons and MAPS Psychedelic Science conferences. He is a founder of several discussion salons on integral philosophy, governance, media, postmodern science, healing, and the future of society.
Trained in humanistic, transpersonal, and eastern traditions, Dr. Goldsmith maintains a (non-psychedelic) psychotherapy practice in New York and Sag Harbor, NY, and may be reached via his Web site: http://www.nealgoldsmith.com/psychedelics. Continue reading “Neal M. Goldsmith, Ph.D. – Psychedelic Healing”
Download
In this episode we talk about the following:
Bio via Psymposia – Katherine MacLean is an academically trained research scientist and meditation practitioner with a long-standing interest in the brain, consciousness and the science of well-being. As a graduate student at the University of California, Davis, Katherine was supported by a prestigious National Science Foundation research fellowship to study the effects of intensive meditation training on concentration, emotional well-being and brain function.
As a postdoctoral fellow and faculty member at the Johns Hopkins University School of Medicine, she was one of the only scientists in the world studying psilocybin — a psychedelic chemical found naturally in certain types of mushrooms. Her groundbreaking research on psilocybin and personality change suggests that psychedelic medicines may be the key to enhancing mental health and promoting openness and creativity throughout the lifespan.
Download
In this episode we talk to Ingmar about some great topics that included.
Ingmar Gorman, M.A. is a currently unlicensed doctoral student in Clinical Psychology at the New School for Social Research. His clinical work is supervised by licensed clinical psychologists at his training sites. After receiving his B.A. in Psychology from the New College of Florida. Ingmar completed a pre-doctoral externship at Bellevue’s Chemical Dependency Outpatient Program and Dual Diagnosis Inpatient Unit, where he obtained specialized training in treating people living with substance use disorders. He has also gained extensive experience treating severe mental illness at South Beach Psychiatric Hospital’s Heights Hill Outpatient Clinic. Ingmar has trained in individual and group psychotherapy at Beth Israel Medical Center’s Psychiatric Inpatient Services, as well as the Brief Psychotherapy Research Program. Ingmar uses an integrative approach to treatment utilizing Cognitive Behavioral Therapy (CBT) and Psychodynamic principles. When treating substance misuse, Ingmar draws on his extensive training with Dr. Andrew Tatarsky and Dr. Jen Talley, in Harm Reduction Psychotherapy and Mindfulness based approaches.
Links
Center for Optimal Living – Psychedelic Program
Upcoming Zendo Training in NYC (Training for harm reduction at festivals)
Download
Lex, Kyle and Joe discuss MAPS, Psymposia, Ibogaine, Mushrooms, Ketamine, LSD, Cannabis, and loads more. Lex is working on a book related to the supremely complex neurochemistry of cannabis.
“Whales, Cannabis and Neurochemistry”
Lex — http://www.lexpelger.com/
Tea Farie Iboga Story https://www.erowid.org/columns/teafaerie/2014/12/18/hard-reset/
Dimitri — https://www.youtube.com/watch?v=DvEv5trIdrg
Nese — http://www.psymposia.com/magazine/preview/nese-devenot-coming-out-of-the-psychedelic-closet
Ketamine — https://clinicaltrials.gov/ct2/show/NCT00088699
Bluebird Botanticals — https://www.bluebird-botanicals.com/
